EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 22-Jun-2026 04:16 ET (22-Jun-2026 08:16 GMT/UTC)

Routine scans may reveal tumor aggressiveness in head and neck cancer – without additional tests

Umea University
Peer-Reviewed Publication

Medical imaging routinely used in cancer care may hold far more biological information than previously thought. An international study involving Umeå University guest professor Lukas Kenner shows that PET/CT scans can capture the molecular activity of particularly aggressive head and neck tumours, opening new possibilities for more precise diagnosis and treatment planning.

Journal: Molecular Cancer

UMass Chan scientist Marcus Ruscetti receives 2026 Pershing Square Sohn Cancer Prize

UMass Chan Medical School
Grant and Award Announcement

Marcus Ruscetti, PhD, received a $750,000 2026 Pershing Square Sohn Cancer Prize to advance his lab’s pancreatic cancer research at UMass Chan Medical School.

AI-powered handheld microscope aims to spot cancer earlier

Rice University
Peer-Reviewed Publication

Researchers at Rice University and The University of Texas MD Anderson Cancer Center have developed a compact, artificial intelligence-powered imaging device that could transform how clinicians detect cancer.

Journal: Proceedings of the National Academy of Sciences

First-in-human trial demonstrates promise of implantable cytokine factories for ovarian cancer

Rice University
Peer-Reviewed Publication

Rice researchers and collaborators at MD Anderson report results from a first-in-human trial evaluating a novel cell-based therapeutic platform in patients with advanced ovarian cancer.

Journal: Clinical Cancer Research
Funder: Advanced Research Projects Agency for Health, Cancer Prevention and Research Institute of Texas

Stage IV breast cancer incidence and survival, 2010-2021

JAMA Network
Peer-Reviewed Publication

In this cohort study of individuals with stage IV breast cancer, incidence increased significantly overall, across ages, and for both sexes from 2010 through 2021. The percentage of individuals with stage IV vs stages I to III diagnoses also increased. Although overall survival improved, research is warranted to determine factors contributing to increased incidence, including potential changes in natural history of breast cancer, disease screening, and incidence and mortality of other conditions.

Journal: JAMA Network Open

Ivermectin-benzimidazole prescribing following celebrity endorsement

JAMA Network
Peer-Reviewed Publication

Ivermectin-benzimidazole prescribing rose rapidly following celebrity endorsement in January 2025, with disproportionate increases among male patients, white patients, residents of the U.S. South, and individuals with cancer. The elevated prescribing observed among patients with cancer is particularly concerning; individuals facing life-threatening illness may delay or forgo conventional treatments in favor of unproven therapies, potentially allowing their disease to progress.

Journal: JAMA Network Open

Ivermectin prescriptions more than doubled after a celebrity endorsed it as a cancer treatment on a high-profile podcast

University of California - Los Angeles Health Sciences
Peer-Reviewed Publication

Prescriptions for the anti-parasite medication ivermectin doubled in the months following an endorsement by a celebrity during a high-profile podcast as an off-label cancer treatment. The endorsement came on January 9, 2025, when actor Mel Gibson appeared on The Joe Rogan Experience and described three friends with stage IV cancer who he said recovered after taking ivermectin and fenbendazole.

Journal: JAMA Network Open

How immune-related adverse events differ in elderly gastrointestinal vs. lung cancer patients

Chinese Medical Journals Publishing House Co., Ltd.
Peer-Reviewed Publication

Immune checkpoint inhibitors are widely used in elderly cancer patients, but data on tumor-specific immune-related adverse events (irAEs) remain limited. A Chinese Medical Journal study analyzed 407 elderly patients with gastrointestinal (GI) tumors or lung cancer. Results showed higher irAE incidence in lung cancer patients, skin toxicity more prevalent in GI tumor patients, and thyroid dysfunction more common in lung cancer patients. This study provides evidence for personalized safety management of immunotherapy in elderly patients.

Journal: Chinese Medical Journal

Hypertension associated with the risk of extrahepatic cancers in the metabolic dysfunction-associated steatotic liver disease population

Xia & He Publishing Inc.
Peer-Reviewed Publication

Extrahepatic cancers have been recognized as a significant outcome of metabolic dysfunction–associated steatotic liver disease (MASLD), which involves five cardiometabolic risk factors, including hypertension, and is associated with the tumorigenesis of several cancers or with anti-cancer treatment. We aimed to investigate the association between hypertension, liver fibrosis, and extrahepatic cancers in the MASLD population.

Journal: Journal of Clinical and Translational Hepatology

Successfully treated AML patients may hold the key to new CAR T cell therapy

Memorial Sloan Kettering Cancer Center
Peer-Reviewed Publication

A team of researchers from Memorial Sloan Kettering Cancer Center (MSK) has developed a new type of CAR T cell therapy that shows promise against acute myeloid leukemia (AML) in preclinical models.

Journal: Cancer Discovery
Funder: Leukemia and Lymphoma Society

44
45
46
47
48